EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Liver disease in management and outcomes of European and Asian patients with atrial fibrillation: A report from two observational prospective registries

Davide Antonio Mei iD, Tommaso Bucci, Giulio Francesco Romiti iD, Bernadette Corica, Alena Shantsila, Hung-Fat Tse, Giuseppe Boriani iD, Tze-Fan Chao iD, Marco Proietti iD, Gregory Y H Lip iD

European Journal of Clinical Investigation · 2026-04 · 56 (4)

DOI: 10.1111/eci.70193 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift European Journal of Clinical Investigation, online erschienen am 26.03.2026. Verfasst von Davide Antonio Mei und 9 weiteren Autor:innen. Beteiligte Einrichtung: Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverp…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Anticoagulants, Liver Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In patients with atrial fibrillation (AF), the impact of liver disease (LD) on oral anticoagulant (OAC) prescription and outcomes remains unclear, as well as possible differences between European and Asian populations.

Aim

To examine the impact of LD on OAC prescriptions and risks of adverse outcomes in a large cohort of European and Asian AF patients.

Methods

AF patients were derived from two large observational registries held in Europe and Asia. OAC prescription and risk of outcomes were analysed according to LD at baseline. The primary outcome was the composite of all‐cause death and major adverse cardiovascular events (MACEs). Logistic regression assessed associations with OAC prescription, and Cox regression analyses evaluated risks of outcomes. Interaction analyses were performed between European and Asian patients.

Results

Among 15,681 patients (mean age 68.4 ± 10.7 years; 37.1% female), 517 (3.3%) had LD. The OAC prescription rate was similar among European and Asian individuals (6.8% vs. 82.9%, p = .113). After adjustments, LD was associated with lower OAC prescription (OR .67, 95% CI .53–.84), with a greater reduction in European than in Asian patients ( p int = .015). LD was associated with a higher risk of the composite outcome (HR 1.42, 95% CI 1.11–1.81) and MACEs (HR 1.47, 95% CI 1.07–2.02), with no significant European versus Asian differences ( p int = .631). Among LD patients, those not prescribed OAC had a higher MACE risk compared with those prescribed OAC ( p int = .050), with no differences in major bleeding.

Conclusions

In AF, LD is associated with reduced OAC prescription, especially in Europe, and a higher risk of adverse outcomes, particularly in patients not receiving OAC, with no significant differences between European and Asian cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationAnticoagulantsLiver DiseasesHumansFemaleMaleAgedRegistriesEuropeMiddle AgedProspective StudiesAsiaStrokeAsian PeopleAdministration, OralEuropean PeopleWhite PeopleProportional Hazards ModelsCause of Death

Stichwörter der Autor:innen

atrial fibrillationliver diseaseoral anticoagulationoutcomes

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, UK.
  • Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, Italy University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy.
  • Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy.
  • Department of Translational and Precision Medicine, Sapienza - University of Rome, Rome, Italy.
  • Division of Cardiology, Department of Medicine, School of Clinical Medicine, Queen Mary Hospital, the University of Hong Kong, Hong Kong, SAR, China.
  • Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.

ORCID-Profile: Davide Antonio Mei, Giulio Francesco Romiti, Giuseppe Boriani, Tze-Fan Chao, Marco Proietti, Gregory Y H Lip

Zitieren

APA

Mei, D. A., Bucci, T., Romiti, G. F., Corica, B., Shantsila, A., Tse, H. F., Boriani, G., Chao, T. F., Proietti, M., & Lip, G. Y. H. (2026). Liver disease in management and outcomes of European and Asian patients with atrial fibrillation: A report from two observational prospective registries. European Journal of Clinical Investigation, 56(4). https://doi.org/10.1111/eci.70193

Vancouver

Mei DA, Bucci T, Romiti GF, Corica B, Shantsila A, Tse HF, et al. Liver disease in management and outcomes of European and Asian patients with atrial fibrillation: A report from two observational prospective registries. European Journal of Clinical Investigation. 2026;56(4). doi:10.1111/eci.70193

BibTeX
@article{Mei2026,
  author = {Mei, Davide Antonio and Bucci, Tommaso and Romiti, Giulio Francesco and Corica, Bernadette and Shantsila, Alena and Tse, Hung-Fat and Boriani, Giuseppe and Chao, Tze-Fan and Proietti, Marco and Lip, Gregory Y H},
  title = {Liver disease in management and outcomes of European and Asian patients with atrial fibrillation: A report from two observational prospective registries},
  journal = {European Journal of Clinical Investigation},
  year = {2026},
  volume = {56},
  number = {4},
  doi = {10.1111/eci.70193}
}
Kostenlos starten →